Skip to main content

Table 1 Characteristics of studies and participants included in the meta-analysis

From: Lipid profile in girls with precocious puberty: a systematic review and meta-analysis

No.

Study

Region

Study design

Sample size (n)

Chronological Age(y)

Bone Age

Tanner stage

BMI(kg/m2)

Drug used

Measuring method

Primary conclusion

Cases

Control

Cases

Control

Cases

Control

Cases

Control

Cases

Control

1.

Ibáñez

(1998) [43]

Spain

(Barcelona)

cross-sectional study

PP

21

14

7.5 ± 0.2

8.5 ± 0.3

8.6 ± 0.2

7.8 ± 0.3

I

I

18.8 ± 0.6

17.0 ± 0.4

No

CHOD-PAP and GPO-PAP based methods in a Hitachi 917 autoanalyser (Boehringer Mannheim, Mannheim, Germany)

TG increased in PP; TC, HDL, LDL remained unchanged in PP

2.

Ibáñez

(2004)

[22]

Spain

(Barcelona)

cross-sectional study

PP

33

37

8.0 ± 0.57

8.3 ± 1.83

9.1 ± 0.57

NA

I

I

18.5 ± 0.3

17.7 ± 0.4

No

NA

TG and LDL increased in PP; HDL decreased in PP

3.

Teixeira

(2004)

[25]

Brazil

(Rio de Janeiro)

cross-sectional study

PP

25

14

7.3 ± 1.5

6.4 ± 1.3

NA

NA

NA

NA

19.7 ± 4.4

19.3 ± 4.6

NA

TC, HDL and TG were measured by an automated enzymatic colorimetric method; LDL was calculated using the Friedewald formula

TG, TC, HDL and LDL remained unchanged in PP

4.

Guven

(2005)

[44]

Turkey

(Ankara)

cross-sectional study

PA

24

13

7.6 ± 0.1

6.9 ± 0.3

7.6 ± 0.2

6.4 ± 0.4

II

II

17.1 ± 0.33

15.9 ± 0.4

No

TC, TG and HDL were measured by the Abbott-Aeroset system through enzyme assay; LDL was estimated by indirect calculation

TC and LDL increased in PA; TG and HDL remained unchanged in PA

5.

Larqué

(2010)

[26]

Spain

(Granada)

cross-sectional study

PP

22

20

8.34 ± 0.29

9.12 ± 0.37

NA

NA

I

I

19.33 ± 0.71

17.30 ± 0.60

No

Automatic analyzer (Roche-Hitachi Modular PyD Autoanalyzer, Roche Laboratory Systems)

TG, TC, HDL and LDL remained unchanged in PP

6.

Sorensen

(2010)

[45]

Denmark

(Copenhagen)

cross-sectional study

CPP

15

24

8.67 ± 1.96

9.26 ± 3.15

NA

NA

II, III

I

18.9 ± 3.4

16.21 ± 4.18

13 girls with CPP were initiated on long-acting

GnRHa treatment with sc injections

every 28th day

Enzymatic colorimetric analyses (CFAS TC/LDL/HDL plus, TG GPO-PAP; Roche)

TG increased in CPP; TC, HDL and LDL remained unchanged in CPP

7.

Sopher

(2011)

[27]

USA

(New York)

cross-sectional study

PA

24

25

7.7 ± 1.4

7.2 ± 1.5

NA

NA

I

I

1.2 ± 1.1

(z-score)

1.8 ± 1.0

(z-score)

No

TC, HDL, and TG by Hitachi analyzer; LDL was calculated

TG, TC, HDL and LDL remained unchanged in PA

8.

Su

(2012)

[28]

Taiwan

(Taichung)

cross-sectional study

CPP

249

219

8.5 ± 1.4

8.3 ± 1.4

10.4 ± 1.5

8.9 ± 2.1

134 II,

115 III

90 I,

129 II

18.7 ± 2.9

17.6 ± 3.5

No

Enzymatic color test and Olympus analyzers (AU600, Clare, Ireland)

TG and TC remained unchanged in CPP

9.

Ucar

(2013)

[23]

Turkey

(Kayseri)

cross-sectional study

PA

69

45

7.1 ± 1.0

7.5 ± 1.9

NA

NA

NA

NA

0.5 ± 1.2

(SDS)

0.2 ± 1.1

(SDS)

NA

Integra-800 autoanalyzer (Roche)

TG and LDL decreased in PA; HDL increased in PA; TC remained unchanged in PA

10.

Hur

(2017)

[29]

Korea

(Seoul)

cross-sectional study

CPP

164

67

8.3 ± 0.6

7.9 ± 0.6

9.7 ± 0.9

8.2 ± 0.9

II

I

0.3 ± 1.1

(SDS)

0.4 ± 0.9

(SDS)

NA

NA

TG, TC, HDL and LDL remained unchanged in CPP

11.

Zurita-Cruz

(2018)

[30]

México

(Mexico City)

cross-sectional study

CPP

31

22

6.5 ± 2.5

6.0 ± 2.0

NA

NA

II, III

I

1.7 ± 0.4

(z-score)

1.8 ± 0.4

(z-score)

No

Colorimetric enzymatic method (Bayer Diagnostics, Puteaux, France)

TG, HDL and LDL remained unchanged in CPP

12.

Xu

(2019)

[24]

China

(Jinan)

cross-sectional study

PT

263

222

5.3 ± 0.7

5.5 ± 0.8

6.1 ± 1.1

5.9 ± 1.2

II, III

I

15.1 ± 2.6

15.8 ± 2.1

No

AU5800 Chemistry Analyzer (Olympus, Japan)

TC, TG and LDL increased in PT; HDL remained unchanged in PT

13.

Aydin

(2022)

[31]

Sweden

(Uppsala)

cross-sectional study

PA

48

49

7.71 ± 1.0

7.54 ± 0.9

8.2 ± 1.0

7.45 ± 1.4

NA

NA

1.2 ± 1.5

(SDS)

0.94 ± 1.6

(SDS)

No

Absorbance photometry (Roche Diagnostics, Cobas Integra 800 Device)

TC, TG, HDL and LDL remained unchanged in PA

14.

Bezen

(2022)

[32]

Turkey

(Ä°stanbul)

cross-sectional study

PP

35

35

8.3 ± 1.1

8.1 ± 1.0

NA

NA

NA

NA

0.34 ± 0.83

(SDS)

-0.04 ± 0.78

(SDS)

No

Spectrophotometer method in Advia 1800 device

TC, TG, HDL and LDL remained unchanged in PP

  1. CPP-central precocious puberty; PP-premature pubarche; PA-premature adrenarche; PT-prematurethelarche; TG-triglyceride; TC-Total cholesterol; HDL-high density lipoprotein; LDL-low density lipoprotein; BMI- body mass index; GnRHa- gonadotropin releasing hormone agonist; NA- not available